Targeting Kir4.1 To Control Brain Excitability And Seizures
以 Kir4.1 为目标来控制大脑兴奋性和癫痫发作
基本信息
- 批准号:MR/W019752/1
- 负责人:
- 金额:$ 99.03万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2022
- 资助国家:英国
- 起止时间:2022 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Neuronal activity can rapidly elevate extracellular potassium in the brain. Potassium elevations are mechanistically related to increases in nerve cell excitability, potentially leading to abnormal network behaviours such as in epilepsy. Astroglia are essential for maintaining potassium balance, through a buffering mechanism engaging their sodium-potassium pumps. However, new evidence attributes the dynamic regulation of extracellular potassium mainly to astroglial channels of the Kir4.1 type whereas downregulation of these channels has been associated with enhanced seizure susceptibility and, in the long term, sclerotic abnormalities of brain tissue. Despite the importance of Kir4.1 for brain excitability control, the causal relationships between Kir4.1 expression, potassium dynamics, local neuronal excitability and synaptic function remain poorly understood. The lack of progress stems from the poorly understood and often counteracting consequences of extracellular potassium rises, from the lack of tools to monitor potassium dynamics in brain tissue, and from the poor access to the sponge-like, nanoscopic morphology of astroglia. The main goal of the present proposal is therefore to understand how the Kir4.1-dependent potassium buffering by astrocytes regulates neural excitability and synaptic circuit function, and whether targeting these mechanisms, pharmacologically or genetically, can alter susceptibility to runaway excitation and seizures. Thus, the central hypothesis is that the varied expression of astroglial Kir4.1 regulates, in a mechanistically predictable manner, cell excitability and synaptic signal transfer. The key translational aspect of the proposal is that the controlled manipulation of Kir4.1 expression should ameliorate pathological changes in neural excitability, such as those during epilepsy or cortical spreading depression. To achieve our goal, we will take advantage of our novel and cutting-edge experimental and theoretical approaches. We have established gene-targeting protocols to enable single-cell studies in Kir4.1-overexpressing astrocytes while simultaneously monitoring neurotransmitter release at local synaptic connections. We have embarked on a novel nanoengineering technology to monitor potassium, which involves encapsulation of the ratiometric optical sensor into ion-permeable, biologically compatible microcapsules. We have established a novel biophysical modelling platform that enables theoretical probing of the intra- and extracellular potassium dynamics in realistic astrocyte models. We have developed a novel multi-electrode electrocorticography technique based on flexible graphene transistor arrays enabling full-band current recordings in awake animals. These and related methodological breakthroughs, backed by a large body of pilot and proof-of-principle data, helped us to formulate a feasible research strategy for achieving our main goal. The plan includes five specific objectives addressed in five work packages. The results will provide new knowledge about the mechanisms by which astroglia regulate neuronal excitability through the Kir4.1-dependent control of extracellular potassium dynamics. Based on such knowledge, a therapeutic strategy could be developed that helps reduce brain susceptibility to runaway excitation, such as seen in epilepsy and related disorders.
神经元活动可以迅速升高大脑中的细胞外钾。钾升高在机制上与神经细胞兴奋性的增加有关,可能导致异常的网络行为,例如癫痫。星形胶质细胞通过钠钾泵的缓冲机制维持钾平衡至关重要。然而,新的证据将细胞外钾的动态调节主要归因于 Kir4.1 类型的星形胶质细胞通道,而这些通道的下调与癫痫易感性增强以及从长远来看与脑组织硬化异常有关。尽管 Kir4.1 对于大脑兴奋性控制很重要,但 Kir4.1 表达、钾动力学、局部神经元兴奋性和突触功能之间的因果关系仍然知之甚少。缺乏进展的原因在于人们对细胞外钾升高的认识知之甚少,而且常常会产生抵消作用,缺乏监测脑组织中钾动态的工具,以及难以获得海绵状、纳米级的星形胶质细胞形态。因此,本提案的主要目标是了解星形胶质细胞的 Kir4.1 依赖性钾缓冲如何调节神经兴奋性和突触回路功能,以及是否从药理学或遗传上针对这些机制,可以改变对失控兴奋和癫痫发作的易感性。因此,中心假设是星形胶质细胞 Kir4.1 的不同表达以机械可预测的方式调节细胞兴奋性和突触信号传递。该提案的关键转化方面是,Kir4.1 表达的受控操作应该改善神经兴奋性的病理变化,例如癫痫或皮质扩散性抑郁期间的病理变化。为了实现我们的目标,我们将利用我们新颖且前沿的实验和理论方法。我们已经建立了基因靶向方案,以便能够在 Kir4.1 过表达的星形胶质细胞中进行单细胞研究,同时监测局部突触连接处的神经递质释放。我们已经开始采用一种新颖的纳米工程技术来监测钾,该技术涉及将比率光学传感器封装到离子可渗透的、生物相容的微胶囊中。我们建立了一个新颖的生物物理建模平台,可以对现实星形胶质细胞模型中的细胞内和细胞外钾动力学进行理论探索。我们开发了一种基于柔性石墨烯晶体管阵列的新型多电极皮层电描记技术,可在清醒动物中进行全频带电流记录。这些和相关的方法论突破,在大量试点和原理验证数据的支持下,帮助我们制定了可行的研究策略来实现我们的主要目标。该计划包括五个工作包中涉及的五个具体目标。这些结果将提供关于星形胶质细胞通过 Kir4.1 依赖的细胞外钾动力学控制来调节神经元兴奋性的机制的新知识。基于这些知识,可以开发出一种治疗策略,帮助降低大脑对失控兴奋的敏感性,例如癫痫和相关疾病。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Avoiding interpretational pitfalls in fluorescence imaging of the brain.
避免大脑荧光成像的解释陷阱。
- DOI:http://dx.10.1038/s41583-022-00643-z
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Rusakov DA
- 通讯作者:Rusakov DA
Avoiding bias in fluorescence sensor readout.
避免荧光传感器读数出现偏差。
- DOI:http://dx.10.1038/s41583-023-00768-9
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Rusakov DA
- 通讯作者:Rusakov DA
A misadventure of the correlation coefficient.
相关系数的不幸事件。
- DOI:http://dx.10.1016/j.tins.2022.09.009
- 发表时间:2023
- 期刊:
- 影响因子:15.9
- 作者:Rusakov DA
- 通讯作者:Rusakov DA
Multi-target action of ß-alanine protects cerebellar tissue from ischemic damage.
α-丙氨酸的多靶点作用可保护小脑组织免受缺血性损伤。
- DOI:http://dx.10.1038/s41419-022-05159-z
- 发表时间:2022
- 期刊:
- 影响因子:9
- 作者:Kopach O
- 通讯作者:Kopach O
Human neutrophils communicate remotely via glutamate-induced glutamate release
人类中性粒细胞通过谷氨酸诱导的谷氨酸释放进行远程通信
- DOI:http://dx.10.1101/2022.02.25.482046
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Kopach O
- 通讯作者:Kopach O
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dmitri Rusakov其他文献
Dmitri Rusakov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dmitri Rusakov', 18)}}的其他基金
Memory trace formation at and beyond individual synapses in the intact brain
完整大脑中单个突触内外的记忆痕迹形成
- 批准号:
BB/Y003926/1 - 财政年份:2024
- 资助金额:
$ 99.03万 - 项目类别:
Research Grant
A 3Rs platform for glial research: From animal to human to in-silico models
神经胶质研究的 3R 平台:从动物到人类再到计算机模型
- 批准号:
NC/X001067/1 - 财政年份:2022
- 资助金额:
$ 99.03万 - 项目类别:
Research Grant
Targeted drug delivery to neurons and glia using light- and field-sensitive microcapsules
使用光和场敏感微胶囊将靶向药物递送至神经元和神经胶质细胞
- 批准号:
BB/J001473/1 - 财政年份:2012
- 资助金额:
$ 99.03万 - 项目类别:
Research Grant
Nano-diffusion in the brain: mechanisms and implications examined with time-resolved fluorescence anisotropy imaging
大脑中的纳米扩散:通过时间分辨荧光各向异性成像检查的机制和影响
- 批准号:
G0802216/1 - 财政年份:2009
- 资助金额:
$ 99.03万 - 项目类别:
Research Grant
Modulation of neurotransmitter release by cannabinoid receptors at individual cortical synapses
大麻素受体对单个皮质突触神经递质释放的调节
- 批准号:
G0900613/1 - 财政年份:2009
- 资助金额:
$ 99.03万 - 项目类别:
Research Grant
Probing presynaptic receptor function with two-photon uncaging, Ca2+ imaging and photobleaching
通过双光子解笼、Ca2 成像和光漂白探测突触前受体功能
- 批准号:
G0600368/1 - 财政年份:2007
- 资助金额:
$ 99.03万 - 项目类别:
Research Grant
相似国自然基金
星形胶质细胞Kir4.1影响催产素神经元活动调控产后抑郁的研究
- 批准号:82301739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
少突胶质谱系细胞Kir4.1离子通道介导多发性硬化症的病理机制研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
伏隔核kir4.1通道调控可卡因成瘾行为的机制研究
- 批准号:82171493
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
多肽抑制剂WGTx作用于Kir4.1通道的分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NG2胶质细胞表达Kir4.1离子通道的调控因素及在缺血性脑卒中的作用
- 批准号:
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Identifying New Astrocytic Kir4.1 Channel Modulators for Treating Huntington's Disease
鉴定用于治疗亨廷顿病的新型星形细胞 Kir4.1 通道调节剂
- 批准号:
10681097 - 财政年份:2023
- 资助金额:
$ 99.03万 - 项目类别:
Contributions of Astrocyte Kir4.1/5.1 Channels to Disordered Breathing in Rett Syndrome
星形胶质细胞 Kir4.1/5.1 通道对 Rett 综合征呼吸障碍的影响
- 批准号:
10606795 - 财政年份:2023
- 资助金额:
$ 99.03万 - 项目类别:
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance
Kir4.1/5.1 抑制剂克服利尿剂抵抗的临床前验证
- 批准号:
10740429 - 财政年份:2023
- 资助金额:
$ 99.03万 - 项目类别:
Regulation of Kir4.1/Kir5.1 and renal potassium excretion
Kir4.1/Kir5.1 和肾钾排泄的调节
- 批准号:
10707731 - 财政年份:2023
- 资助金额:
$ 99.03万 - 项目类别:
Extracellular potassium and astrocytic Kir4.1 modulate interneuron activity in the cerebral cortex
细胞外钾和星形细胞 Kir4.1 调节大脑皮层的中间神经元活动
- 批准号:
10621245 - 财政年份:2022
- 资助金额:
$ 99.03万 - 项目类别: